Pancreatic alpha-cell dysfunction in diabetes (Q37221764)

19 August 2017

1 reference

title

Pancreatic alpha-cell dysfunction in diabetes (English)

1 reference

19 August 2017

3

1 reference

19 August 2017

2

C Knauf

1 reference

19 August 2017

R Burcelin

1

1 reference

19 August 2017

publication date

1 February 2008

1 reference

19 August 2017

published in

Diabetes and Metabolism

1 reference

19 August 2017

volume

34 Suppl 2

1 reference

19 August 2017

page(s)

S49-55

1 reference

Negative consequences of glycation.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucagon physiology and pathophysiology in the light of new advances

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Alpha cell function in health and disease: influence of glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Abnormal Secretion of Insulin and Glucagon by the In Vitro Perfused Pancreas of the Genetically Diabetic Chinese Hamster

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Somatostatin induces hyperpolarization in pancreatic islet alpha cells by activating a G protein-gated K+ channel

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse alpha-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Targeting of voltage-gated K+ and Ca2+ channels and soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins to cholesterol-rich lipid rafts in pancreatic alpha-cells: effects on glucagon stimulus-secretion coupling.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Innervation of the canine pancreas after vagotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Interplay of nutrients and hormones in the regulation of glucagon release

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Retrograde perfusion as a model for testing the relative effects of glucose versus insulin on the A cell

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

The Berson memorial lecture. Insulin-glucagon relationships in the defense against hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Evidence that extrapancreatic GLUT2-dependent glucose sensors control glucagon secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Autonomic regulation of islet hormone secretion--implications for health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Differences in adrenergic recognition by pancreatic A and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Parasympathetic innervation and function of endocrine pancreas requires the glial cell line-derived factor family receptor alpha2 (GFRalpha2).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

GLP-1 and extra-islet effects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucagon-like peptide 1 improved glycemic control in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

The incretins: a link between nutrients and well-being

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Effect of Insulin Therapy on the Profiles of Plasma Immunoreactive Glucagon in Juvenile-type and Adult-type Diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Studies of pancreatic alpha cell function in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Abnormal alpha cell function in human diabetes: the response to oral protein

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glycemic control in mice with targeted disruption of the glucagon receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Design and synthesis of glucagon partial agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2973395-0

7 January 2021

10.1016/S1262-3636(08)73395-0

Identifiers

DOI

1 reference

19 August 2017

1 reference